Capstone Partners has released its August Pharmaceutical Outsourcing M&A Report, available for download below. The pandemic has emphasized the need for the industry to rethink its reliance on offshore manufacturing and complex global supply chains, as well as how to utilize technology to adopt a more decentralized approach to conducting clinical trials. While COVID-19 has certainly challenged contract research organizations (CROs) in the administration of on-site activities and clinical trials, it has also fostered heightened innovation and implementation of remote technology. Virtual trials and eClinical solutions have gained increased adoption as CROs seek creative options for decentralized management of clinical trials.
Report contents include:
- M&A Overview
- Short-Term Industry Outlook
- Notable Transactions
- Historic Deal Trends
- Select Transactions
- Public Company Data
To learn more about the report, please reach out to Managing Director, Eric Williams.
Insights for Middle Market Leaders
Receive email updates with our proprietary data, reports, and insights as they’re published for the industries that matter to you most.